110 related articles for article (PubMed ID: 1266193)
21. [Australia antigen and autoantibodies in chronic liver diseases].
Müller R; Kalden J; Deicher H
Verh Dtsch Ges Inn Med; 1972; 78():926-8. PubMed ID: 4665781
[No Abstract] [Full Text] [Related]
22. Hepatitis-B-antigen in chronic liver diseases (author's transl).
Henning H; Tripatzis I; von Braun HH; Lüders CJ
Med Klin; 1973 Nov; 68(46):1503-10. PubMed ID: 4131487
[No Abstract] [Full Text] [Related]
23. [Australia antigen in an African hospital population. Frequency and clinical correlations].
Barbotin M; Oudart JL; Marty M
Nouv Presse Med; 1972 Oct; 1(36):2392-4. PubMed ID: 4628340
[No Abstract] [Full Text] [Related]
24. Role of Australia (Au) antigen in chronic liver disease in infancy and childhood.
Ertuģrul M
Turk J Pediatr; 1974 Jan; 16(1):8-14. PubMed ID: 4218668
[No Abstract] [Full Text] [Related]
25. Immunoglobulins, glycoproteids and Australia antigen in chronic liver disease.
Fehér J; Jakab L; Szilvási I
Acta Med Acad Sci Hung; 1973; 30(3):197-203. PubMed ID: 4132109
[No Abstract] [Full Text] [Related]
26. Hepatitis B surface antigen and immunoglobulin M complexes in chronic carriers and patients with acute and chronic liver diseases.
Ayoola EA; Olubuyide I
Afr J Med Med Sci; 1989 Mar; 18(1):21-4. PubMed ID: 2545079
[TBL] [Abstract][Full Text] [Related]
27. [Distribution of subtype (D and Y) in Australia-antigen (AuAg)-positive hepatopathies].
Kindler U; Schoppe WD; Arnold HG
Med Welt; 1975 Sep; 26(37):1635-7. PubMed ID: 1177725
[No Abstract] [Full Text] [Related]
28. [HBsAg in the hepatocytes in chronic liver diseases].
Loginov AS; Aruin LI; Shepeleva SD; Tkachev VD; Zotina MM
Ter Arkh; 1986; 58(3):71-3. PubMed ID: 3715734
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis B antigen research technics. Epidemiology at a hemodialysis and liver disease center].
Lautier F; Cvoric M; Garcia E; Lavillaureix J
Pathol Microbiol (Basel); 1974; 40(3):204-6. PubMed ID: 4210494
[No Abstract] [Full Text] [Related]
30. Distribution patterns of hepatitis B antigen in the liver. Immunofluorescence studies.
Akeyama T; Kamada T; Koyama M; Abe H
Arch Pathol; 1974 Oct; 98(4):252-6. PubMed ID: 4369930
[No Abstract] [Full Text] [Related]
31. [e/Anti-e system in liver disease].
Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
[TBL] [Abstract][Full Text] [Related]
32. [Australia antigen (Au-SH-HAA)-findings in chronic liver diseases].
Wagner K; Geserick G; Schimmelpfennig W; Theuer D; Lignitz E; Schneider G
Dtsch Gesundheitsw; 1972 Dec; 27(50):2364-7. PubMed ID: 4651197
[No Abstract] [Full Text] [Related]
33. [Demonstration of Australia antigen in chronic liver diseases].
Shimelpofenig V; Vagner K; Toier D; Shnaider G; Gezerik G; Miuler G
Vutr Boles; 1972; 11(3):46-8. PubMed ID: 4679977
[No Abstract] [Full Text] [Related]
34. [Australia antigen and its relation to chronic liver diseases].
Tamev T; Giurov L
Vutr Boles; 1972; 11(3):45-6. PubMed ID: 4679976
[No Abstract] [Full Text] [Related]
35. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis.
Colombo M; Cambieri R; Rumi MG; Ronchi G; Del Ninno E; De Franchis R
Gastroenterology; 1983 Aug; 85(2):235-9. PubMed ID: 6345255
[TBL] [Abstract][Full Text] [Related]
36. [Immunomorphological study of activity and process induced by viral antigens in chronic liver diseases].
Barinskiĭ IF; Semendiaeva ME; Lorie NIu; Bezprozvannyĭ BK
Sov Med; 1976 Dec; (12):47-50. PubMed ID: 1013790
[No Abstract] [Full Text] [Related]
37. Diseases of the alimentary system. Significance of persistent HBs antigenaemia.
Woolf IL; Williams R
Br Med J; 1976 Oct; 2(6039):807-8. PubMed ID: 974623
[No Abstract] [Full Text] [Related]
38. Australia antigen in liver disease in Zambia.
Lowenthal M; Banatvala JE; Chrystie IL; Jones IG; Nag J; Mohelsky V; Hutt MS
Trop Geogr Med; 1973 Mar; 25(1):39-44. PubMed ID: 4348424
[No Abstract] [Full Text] [Related]
39. [Prevalence and clinical significance of the intrahepatic delta agent in chronic HBsAg carriers].
Rumi MG; Cambieri R; Rossi A; Grossi C; Balestrieri M; Vecchi M; Chinea B; Colombo M
Ann Sclavo; 1982; 24(5):528-35. PubMed ID: 6765188
[No Abstract] [Full Text] [Related]
40. [Immunogenetic factors influencing HBV carrier state, the seroconversion and the development of chronic liver disease].
Shimbo M; Ohtsuka S; Sakaya S; Sakamoto S; Ikeda H; Sekiguchi S
Hokkaido Igaku Zasshi; 1990 Jan; 65(1):67-73. PubMed ID: 2328948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
